BioSpace News Archive

According to the report, the global advanced glycation end products market was valued at US$ 1.56 Bn in 2020.

Heidelberg Pharma AG and Huadong Medicine Co., Ltd., Hangzhou, China, announced that the companies have entered into a strategic partnership with the signing of an exclusive licensing agreement as well as an investment agreement.

Photocure ASA, the Bladder Cancer Company, announces the publication of new results from its exploratory research program in the journal Biomedicines, entitled “Antitumor Effect and Induced Immune Response Following Exposure of Hexaminolevulinate and Blue Light in an Orthotopic Model of Rat Bladder Cancer”.

Diadem Srl today announced CE IVD certification for its AlzoSure® Predict prognostic blood test for the early prediction of Alzheimer’s disease (AD).

Myonex, a leading global clinical trial supply company, announces entry into a definitive agreement with the owners of Hubertus Apotheke am Salzufer to acquire the Clinical Trial and Wholesale Drug Business, located in Berlin, Germany.

Lexicon Pharmaceuticals, Inc. reported financial results for the three months and full-year ended December 31, 2021 and provided an update on key milestones.

Exact Sciences Corp., a leader in advanced cancer diagnostics, announced that company management will participate in the following conferences and invited investors to participate by webcast.

MediciNova, Inc. and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MN-166 (ibudilast) was discussed as a potential beneficial pharmacological agent for the treatment of degenerative cervical myelopathy (DCM) in Global Spine Journal.

Apria, Inc. announced today financial results for the fourth quarter and full year ended December 31, 2021.

Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders, today announced that Douglas Love, Esq., president and chief executive officer, will participate in a virtual panel titled, “Orphan CNS Panel,” during the Cowen 42nd Annual Healthcare Conference.